Are you a patient with Complex Regional Pain Syndrome (CRPS)?
We are working with the Northwest Clinical Research Center to help identify patients who may qualify for a study of a new medication protocol involving an IV infusion of Neridronate. Neridronate is thought to provide benefit to some patients with CRPS. (This protocol would be carried at a NWCRC facility, and not at our facility Acute Pain Therapies.) Of note, symptoms of CRPS must have been going on for less than 2 years for a patient to qualify for the study.
We will invite you to come see us to confirm a diagnosis of CRPS from a physical exam standpoint as defined by the study protocol. Evaluation for study candidacy will not cost any money and will not be billed to insurance. If the patient does meet criteria, he/she would move on to the next steps with NWCRC for study enrollment.